These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 32335343)

  • 1. Safety and efficacy of memantine for multiple sclerosis-related fatigue: A pilot randomized, double-blind placebo-controlled trial.
    Falsafi Z; Tafakhori A; Agah E; Mojarrad M; Dehghani R; Ghaffarpour M; Aghamollaii V; Mousavi SV; Fouladi Z; Pourghaz B; Balali P; Harirchian MH
    J Neurol Sci; 2020 Jul; 414():116844. PubMed ID: 32335343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
    Achiron A; Givon U; Magalashvili D; Dolev M; Liraz Zaltzman S; Kalron A; Stern Y; Mazor Z; Ladkani D; Barak Y
    Mult Scler; 2015 May; 21(6):767-75. PubMed ID: 25344375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
    Peyro Saint Paul L; Creveuil C; Heinzlef O; De Seze J; Vermersch P; Castelnovo G; Cabre P; Debouverie M; Brochet B; Dupuy B; Lebiez P; Sartori É; Clavelou P; Brassat D; Lebrun-Frenay C; Daplaud D; Pelletier J; Coman I; Hautecoeur P; Tourbah A; Defer G
    J Neurol Sci; 2016 Apr; 363():69-76. PubMed ID: 27000224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
    Nourbakhsh B; Revirajan N; Morris B; Cordano C; Creasman J; Manguinao M; Krysko K; Rutatangwa A; Auvray C; Aljarallah S; Jin C; Mowry E; McCulloch C; Waubant E
    Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.
    Rammohan KW; Rosenberg JH; Lynn DJ; Blumenfeld AM; Pollak CP; Nagaraja HN
    J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):179-83. PubMed ID: 11796766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial.
    Lovera JF; Frohman E; Brown TR; Bandari D; Nguyen L; Yadav V; Stuve O; Karman J; Bogardus K; Heimburger G; Cua L; Remingon G; Fowler J; Monahan T; Kilcup S; Courtney Y; McAleenan J; Butler K; Wild K; Whitham R; Bourdette D
    Mult Scler; 2010 Jun; 16(6):715-23. PubMed ID: 20483885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of memantine as treatment for spasticity in multiple sclerosis.
    Mehta LR; McDermott MP; Goodman AD; Schwid SR
    Mult Scler; 2010 Feb; 16(2):248-51. PubMed ID: 20028712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial.
    Johnson SK; Diamond BJ; Rausch S; Kaufman M; Shiflett SC; Graves L
    Explore (NY); 2006 Jan; 2(1):19-24. PubMed ID: 16781604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does oral salbutamol improve fatigue in multiple sclerosis? A pilot placebo-controlled study.
    de Almeida GM; Scola RH; Ducci RDP; Cirino RHD; Cláudia SKK; Lorenzoni PJ; Lima PHS; de Oliveira LP; Werneck LC
    Mult Scler Relat Disord; 2020 Nov; 46():102586. PubMed ID: 33296982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment for memory disorder in multiple sclerosis.
    He D; Zhang Y; Dong S; Wang D; Gao X; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008876. PubMed ID: 24343792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue.
    Fitzgerald KC; Morris B; Soroosh A; Balshi A; Maher D; Kaplin A; Nourbakhsh B
    Mult Scler; 2021 May; 27(6):942-953. PubMed ID: 32633662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginseng in the treatment of fatigue in multiple sclerosis: a randomized, placebo-controlled, double-blind pilot study.
    Etemadifar M; Sayahi F; Abtahi SH; Shemshaki H; Dorooshi GA; Goodarzi M; Akbari M; Fereidan-Esfahani M
    Int J Neurosci; 2013 Jul; 123(7):480-6. PubMed ID: 23301896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Stankoff B; Waubant E; Confavreux C; Edan G; Debouverie M; Rumbach L; Moreau T; Pelletier J; Lubetzki C; Clanet M;
    Neurology; 2005 Apr; 64(7):1139-43. PubMed ID: 15824337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B; Revirajan N; Waubant E
    Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose ketamine infusion for the treatment of multiple sclerosis fatigue (INKLING-MS): Study protocol for a randomized, double-blind, active placebo-controlled phase II trial.
    Ghajarzadeh M; Roman S; Vega L; Nourbakhsh B
    Contemp Clin Trials; 2023 Mar; 126():107106. PubMed ID: 36738917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study.
    Bertoglio JC; Baumgartner M; Palma R; Ciampi E; Carcamo C; Cáceres DD; Acosta-Jamett G; Hancke JL; Burgos RA
    BMC Neurol; 2016 May; 16():77. PubMed ID: 27215274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study.
    Kim E; Cameron M; Lovera J; Schaben L; Bourdette D; Whitham R
    Mult Scler; 2011 Dec; 17(12):1523-6. PubMed ID: 21803872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dalfampridine in the treatment of primary fatigue in patients with multiple sclerosis: a randomized clinical trail.
    Mavandadi S; Paybast S; Mirzadeh M; Mozhdehipanah H
    Acta Neurol Belg; 2024 Aug; 124(4):1289-1294. PubMed ID: 38582798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
    Ledinek AH; Sajko MC; Rot U
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S86-9. PubMed ID: 24321164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.